MBPL3822 Chemotherapy CAT 1 – 33 MCQs | Kenya MBChB

33 Year 2: Microbiology exam questions on MBPL3822 Chemotherapy CAT 1 for medical students. Includes MCQs, answers, explanations and written questions. Sample:

This MCQ set contains 33 questions on MBPL3822 Chemotherapy CAT 1 in the Year 2: Microbiology unit. Each question includes the correct answer and a detailed explanation for active recall and exam preparation.

Q1: Which one of the following antibiotics is likely to be most effective agent in the treatment of an infection due to enterococci if used in conjunction with penicillin G? (Application question)

  1. A. Streptomycin
  2. B. Amikacin
  3. C. Gentamicin
  4. D. Tobramycin
  5. E. Netilmicin

Correct answer: C – Gentamicin

Gentamicin, when used in combination with penicillin G, shows synergistic activity against enterococci. The penicillin disrupts the cell wall, allowing better penetration of the aminoglycoside (gentamicin) into the bacterial cell, resulting in enhanced bactericidal activity. ---

Q2: Regarding the antibacterial action of gentamicin, which one of the following statements is the MOST accurate? (Application question)

  1. A. Antibacterial activity is often reduced by the presence of an inhibitor of cell wall synthesis
  2. B. Efficacy is directly proportionate to the time that the plasma level of the drug is greater than the minimal inhibitory concentration
  3. C. Gentamicin continues to exert antibacterial effects even after plasma levels decrease below detectable levels
  4. D. The antibacterial action of gentamicin is not concentration-dependent
  5. E. The antibacterial action of gentamicin is time-dependent

Correct answer: C – Gentamicin continues to exert antibacterial effects even after plasma levels decrease below detectable levels

Gentamicin exhibits a post-antibiotic effect (PAE) , meaning it continues to suppress bacterial growth even after drug concentrations fall below the minimum inhibitory concentration (MI C). This is characteristic of concentration-dependent antibiotics like aminoglycosides. ---

Q3: A 24-year-old woman is diagnosed with genital herpes simplex virus infection. Which agent is indicated for use in this diagnosis?

  1. A. Zanamivir
  2. B. Cidofovir
  3. C. Ganciclovir
  4. D. Valacyclovir

Correct answer: D – Valacyclovir

Valacyclovir, famciclovir, penciclovir, and acyclovir are all indicated for herpes simplex virus infection. Cidofovir and ganciclovir are used for CMV retinitis. Zanamivir is indicated for influenza. ---

Q4: A 72-year-old man is admitted to the hospital from a nursing home with severe pneumonia. He was discharged from the hospital 1 week ago after open heart surgery. The patient has no known allergies. Which of the following regimens is most appropriate for empiric coverage of methicillin-resistant Stap

  1. A. Vancomycin + cefepime + ciprofloxacin
  2. B. Vancomycin + cefazolin + ciprofloxacin
  3. C. Telavancin + cefepime + ciprofloxacin
  4. D. Daptomycin + cefepime + ciprofloxacin

Correct answer: A – Vancomycin + cefepime + ciprofloxacin

Vancomycin provides adequate coverage against MRSA, and cefepime and ciprofloxacin provide adequate empiric coverage of Pseudomonas. Option B is incorrect because cefazolin does not have activity against Pseudomonas. Option C is incorrect because telavancin should be avoided if possible with drugs that prolong the QTc interval (ciprofloxacin). Daptomycin is inactivated by pulmonary surfactant and

Q5: Select the agent which evades acquired efflux and target-mediated resistance

  1. A. Tigecycline
  2. B. Minocycline
  3. C. Tetracycline
  4. D. Doxycycline

Correct answer: A – Tigecycline

Tigecycline is the first glycylcycline to be launched and is one of the very few new antimicrobials with activity against Gram-negative bacteria. It evades acquired efflux and target-mediated resistance to classical tetracyclines, but not chromosomal efflux in Proteeae and Pseudomonas. It has shown equivalence to imipenem/cilastatin in intra-abdominal infections and is useful for treating multires

Q6: Superinfections are more common with

  1. A. Use of narrow spectrum antibiotics
  2. B. Use of antibiotics that are completely absorbed from the small intestines
  3. C. Short courses of antibiotics
  4. D. Use of antibiotic combinations covering both gram positive and gram negative bacteria
  5. E. difficile or Candid

Correct answer: D – Use of antibiotic combinations covering both gram positive and gram negative bacteria

Broad-spectrum antibiotics or antibiotic combinations that cover both gram-positive and gram-negative bacteria disrupt the normal flora more extensively, allowing opportunistic organisms (like C. difficile or Candida) to overgrow, leading to superinfections. ---

Q7: Which one of the following drugs is most likely to be effective against multi-drug-resistant (MDR) strains of M tuberculosis, including those resistant to streptomycin?

  1. A. Spectinomycin
  2. B. Clarithromycin
  3. C. Amikacin
  4. D. Gentamicin
  5. E. Meropenem

Correct answer: C – Amikacin

Amikacin is an aminoglycoside that is often effective against MDR-TB strains, including those resistant to streptomycin. It is one of the second-line agents used in the treatment of drug-resistant tuberculosis due to its different resistance profile compared to streptomycin. ---

Q8: A 77-year-old woman was started on antibiotics for pneumonia treatment. After 3 days of antibiotic therapy, the serum creatinine doubled. Which of the following antibiotics is most likely responsible for this increase in serum creatinine?

  1. A. Doxycycline
  2. B. Tobramycin
  3. C. Linezolid
  4. D. Clarithromycin

Correct answer: B – Tobramycin

Aminoglycosides such as tobramycin accumulate in the proximal tubular cells of the kidney and disrupt calcium-mediated transport processes. This results in kidney damage ranging from mild, reversible renal impairment to severe, potentially irreversible acute tubular necrosis. Nephrotoxicity is not commonly associated with tetracyclines, macrolides, or oxazolidinones. ---

Q9: The persistent suppression of bacterial growth that may occur following limited exposure to some antimicrobial drugs is called

  1. A. Concentration-dependent killing
  2. B. Sequential blockade
  3. C. Clinical synergy
  4. D. The post antibiotic effect
  5. E. Time-dependent killing

Correct answer: D – The post antibiotic effect

The post-antibiotic effect (PAE) is the continued suppression of bacterial growth after brief exposure to an antimicrobial agent, even after drug concentrations have fallen below the MIC. This is particularly notable with aminoglycosides and fluoroquinolones. ---

Q10: Select the antibiotic whose dose must be reduced in patients with renal insufficiency

  1. A. Ampicillin
  2. B. Erythromycin
  3. C. Chloramphenicol
  4. D. Tobramycin
  5. E. Isoniazid

Correct answer: D – Tobramycin

Tobramycin (an aminoglycoside) is primarily eliminated by the kidneys through glomerular filtration. In patients with renal insufficiency, the drug can accumulate to toxic levels, so dose adjustment is necessary to prevent nephrotoxicity and ototoxicity. ---

Q11: Isoniazid is a primary antitubercular agent that

  1. A. May discolor the tears, saliva, urine or feces orange-red
  2. B. May be ototoxic and nephrotoxic
  3. C. Requires pyridoxine supplementation
  4. D. Causes ocular complications that are reversible if the drug is discontinued
  5. E. Should never be used due to hepatotoxic potential

Correct answer: C – Requires pyridoxine supplementation

Isoniazid can cause peripheral neuropathy by interfering with pyridoxine (vitamin B6) metabolism. Pyridoxine supplementation is given to prevent this adverse effect, especially in high-risk patients (diabetics, alcoholics, malnourished individuals, pregnant women). ---

Q12: Linezolid would be a good choice for antibiotic treatment in which of the following patient scenarios?

  1. A. Bacteremia caused by Staphylococcus aureus
  2. B. Urinary tract infection caused by Escherichia coli
  3. C. Diabetic foot infection caused by Pseudomonas aeruginosa
  4. D. Pneumonia caused by drug-resistant Streptococcus pneumoniae
  5. E. It is not an optimal choice for treatment of bacteremia (static, not cidal). Linezolid also does not have gram-negative coverage against

Correct answer: D – Pneumonia caused by drug-resistant Streptococcus pneumoniae

Linezolid has excellent coverage against resistant gram-positive organisms including drug-resistant S. pneumoniae. It is not an optimal choice for treatment of bacteremia (static, not cidal). Linezolid also does not have gram-negative coverage against E. coli and P. aeruginosa. ---

Q13: In the empiric treatment of severe bacterial infections of unidentified etiology, this drug, often used in combination with an aminoglycoside, provides coverage against many staphylococci

  1. A. Clavulanic acid
  2. B. Tetracycline
  3. C. Erythromycin
  4. D. Nafcillin
  5. E. Amoxicillin

Correct answer: D – Nafcillin

Nafcillin is a penicillinase-resistant penicillin that provides excellent coverage against methicillin-sensitive Staphylococcus aureus (MSSA). It is often used in combination with aminoglycosides for empiric treatment of severe infections where staphylococcal involvement is suspected. ---

Q14: Which of the following statements accurately describes the difference in spectrum of activity between erythromycin and azithromycin?

  1. A. Erythromycin has better activity against gram-negatives such as H. influenza
  2. B. Azithromycin has better activity against respiratory pathogens such as Haemophilus influenzae and Moraxella catarrhalis but less potent activity again
  3. C. Erythromycin has the same activity as azithromycin against gram-positives and gram-negatives
  4. D. Azithromycin has better activity against staphylococci and streptococci compared to erythromycin

Correct answer: B – Azithromycin has better activity against respiratory pathogens such as Haemophilus influenzae and Moraxella catarrhalis but less potent activity again

Azithromycin has improved activity against gram-negative respiratory pathogens like H. influenzae and M. catarrhalis compared to erythromycin, but erythromycin has better activity against gram-positive organisms (staphylococci and streptococci). ---

Q15: Regarding the lipid formulation of amphotericin B, which one of the following statements is accurate? (Application question)

  1. A. They have wider spectrums of antifungal activity than conventional formulations of amphotericin B
  2. B. They are less expensive to use than conventional amphotericin B
  3. C. They are more effective in fungal infections because they increase tissue uptake of amphotericin B
  4. D. They may decrease nephrotoxicity of amphotericin B
  5. E. Affinity of amphotericin B for these lipids is greater than affinity for ergosterol

Correct answer: D – They may decrease nephrotoxicity of amphotericin B

Lipid formulations of amphotericin B (liposomal, lipid complex) have the same spectrum of activity but significantly reduced nephrotoxicity compared to conventional amphotericin B. The lipid carrier preferentially delivers the drug to tissues rather than kidneys, reducing renal toxicity while maintaining antifungal efficacy. ---

Q16: The mechanism of antibacterial action of tetracycline involves

  1. A. Binding to a component of the 50S ribosomal subunit
  2. B. Inhibition of DNA-dependent RNA polymerase
  3. C. Blockade of binding of aminoacyl-tRNA to bacterial ribosomes
  4. D. Selective inhibition of ribosomal peptidyl transferases
  5. E. Inhibition of translocase activity

Correct answer: C – Blockade of binding of aminoacyl-tRNA to bacterial ribosomes

Tetracyclines bind to the 30S ribosomal subunit and prevent the binding of aminoacyl-tRNA to the acceptor site on the ribosome, thereby inhibiting protein synthesis. This is a bacteriostatic mechanism. ---

Q17: In which of the following groups do all four drugs warrant careful monitoring for drug-related seizures in high-risk patients? (Application question)

  1. A. Imipenem, tetracycline, vancomycin, sulfadiazine
  2. B. Penicillin G, chloramphenicol, tetracycline, vancomycin
  3. C. Cycloserine, metronidazole, vancomycin, sulfadiazine
  4. D. Penicillin G, imipenem, amphotericin B, metronidazole
  5. E. Metronidazole, imipenem, doxycycline, erythromycin

Correct answer: D – Penicillin G, imipenem, amphotericin B, metronidazole

All four drugs in this group (Penicillin G, imipenem, amphotericin B, and metronidazole) can lower the seizure threshold and cause seizures, especially in high-risk patients (those with renal impairment, CNS disorders, or receiving high doses). These drugs require careful monitoring for neurological adverse effects. ---

Q18: Penicillins interfere with bacterial cell wall synthesis by

  1. A. Inhibiting conjugation between N-acetyl muramic acid and N-acetyl glucosamine
  2. B. Inhibiting transpeptidases and carboxypeptidases which cross link the peptidoglycan residues
  3. C. Counterfeiting for D-alanine in the bacterial cell wall
  4. D. Inhibiting synthesis of N-acetyl muramic acid pentapeptide

Correct answer: B – Inhibiting transpeptidases and carboxypeptidases which cross link the peptidoglycan residues

Penicillins are β-lactam antibiotics that inhibit bacterial transpeptidases (also called penicillin-binding proteins or PBPs), which are essential for cross-linking peptidoglycan chains in the bacterial cell wall. This weakens the cell wall and leads to bacterial cell lysis. ---

Q19: Which of the following statements about vancomycin is accurate?

  1. A. Staphylococcal enterocolitis occurs commonly with its use
  2. B. It is not susceptible to penicillinase
  3. C. It binds to PBPs
  4. D. It has the advantage of oral bioavailability
  5. E. It is bacteriostatic

Correct answer: B – It is not susceptible to penicillinase

Vancomycin is a glycopeptide antibiotic that is not affected by β-lactamases (penicillinases) because it has a completely different structure and mechanism of action from β-lactam antibiotics. It inhibits cell wall synthesis by binding to D-alanyl-D-alanine terminals, not to PBPs. ---

Q20: A 36-year-old woman recently treated for leukemia is admitted to hospital with malaise, chills and high fever. Gram stain of blood reveals the presence of gram-negative bacilli. The initial diagnosis is bacteremia and parenteral antibiotics are indicated. The records of the patient reveal that she h

  1. A. Cefazolin
  2. B. Ampicillin plus sulbactam
  3. C. Aztreonam
  4. D. Imipenem plus cilastatin
  5. E. Ticarcillin plus clavulanic acid

Correct answer: C – Aztreonam

The patient has a documented severe penicillin allergy (anaphylaxis). Aztreonam is a monobactam that has no cross-reactivity with penicillins and can be safely used in penicillin-allergic patients. It provides good gram-negative coverage. Cephalosporins and carbapenems have potential cross-reactivity with penicillins and should be avoided in severe allergic reactions. ---

Q21: Clarithromycin and erythromycin have very similar spectrums of antimicrobial activity. The major advantage of clarithromycin is that it

  1. A. Is active against strains of streptococci that are resistant to erythromycin
  2. B. Is more active against Mycobacterium avium complex
  3. C. Acts on methicillin-resistant strains of staphylococci
  4. D. Does not inhibit liver drug-metabolizing enzymes
  5. E. Eradicates mycoplasmal infections in a single dose

Correct answer: B – Is more active against Mycobacterium avium complex

Clarithromycin has greater intracellular activity than erythromycin against Mycobacterium avium complex (MAC), making it a preferred agent for MAC infections, particularly in HIV-infected individuals. Both drugs have similar spectrums against typical bacteria, but clarithromycin's enhanced activity against MAC is a key distinguishing feature. ---

Q22: The primary mechanism underlying the resistance of gram-positive organisms to macrolide antibiotics is

  1. A. Methylation of binding sites on the 50S ribosomal subunit
  2. B. Formation of esterases that hydrolyze the lactone ring
  3. C. Increased activity of efflux mechanisms
  4. D. Formation of drug-inactivating acetyltransferases
  5. E. Decreased drug permeability of the cytoplasmic membrane

Correct answer: A – Methylation of binding sites on the 50S ribosomal subunit

The most common mechanism of macrolide resistance in gram-positive bacteria is methylation of the 23S rRNA component of the 50S ribosomal subunit (mediated by erm genes). This modification prevents macrolide binding to the ribosome, conferring resistance. ---

Q23: Which fluoroquinolone has markedly enhanced activity against gram positive bacteria and anaerobes?

  1. A. Ciprofloxacin
  2. B. Levofloxacin
  3. C. Norfloxacin
  4. D. Moxifloxacin
  5. E. , maintains gram-negative coverage, and gains anaerobic coverag

Correct answer: D – Moxifloxacin

Moxifloxacin is a 4th generation fluoroquinolone with improved gram-positive coverage (including S. pneumoniae), maintains gram-negative coverage, and gains anaerobic coverage. This broader spectrum distinguishes it from earlier fluoroquinolones like ciprofloxacin. ---

Q24: A 20-year-old woman presents to the emergency room with headache, stiff neck, and fever for 2 days and is diagnosed with meningitis. Which is the best agent for the treatment of meningitis in this patient?

  1. A. Cefdinir
  2. B. Cefuroxime axetil
  3. C. Cefotaxime
  4. D. Cefazolin

Correct answer: C – Cefotaxime

Cefotaxime is a 3rd generation cephalosporin with excellent CSF penetration and broad coverage against common meningitis pathogens (S. pneumoniae, N. meningitidis, H. influenzae). Cefdinir and cefuroxime axetil are only available orally and not appropriate for serious CNS infections. Cefazolin has inadequate CSF penetration and spectrum. ---

Q25: A 68-year-old man presents from a nursing home with fever, increased urinary frequency and urgency, and mental status changes. He has a penicillin allergy of anaphylaxis. Which of the following β-lactams is the most appropriate choice for gram-negative coverage of this patient's urinary tract infect

  1. A. Aztreonam
  2. B. Ceftaroline
  3. C. Cefepime
  4. D. Ertapenem

Correct answer: A – Aztreonam

Aztreonam is a monobactam with no cross-reactivity with penicillins and can be safely given to penicillin-allergic patients, even those with anaphylaxis. Although cross-reactivity between cephalosporins/carbapenems and penicillins is low (<1-10%), the risk rarely outweighs the benefit in cases of documented anaphylaxis. Aztreonam provides good gram-negative coverage for UTI. ---

View on OmpathStudy